PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

NIH spent $8.1B for phased clinical trials of drugs approved 2010-19, ~10% of reported industry spending

Bentley University study further describes public and private sector investments in pharmaceutical innovation

NIH spent $8.1B for phased clinical trials of drugs approved 2010-19, ~10% of reported industry spending
2023-07-14
(Press-News.org) BENTLEY UNIVERSITY

The U.S. National Institutes of Health (NIH) contributed $8.1 billion in project funding for phased clinical trials involving drugs approved by the FDA from 2010-2019, according to a new study from Bentley University’s Center for Integration of Science and Industry. The study, published in JAMA Health Forum, shows that NIH funding for clinical trials represents <3.5% of total NIH spending for basic or applied research related to these products and was significantly less than reported industry spending on clinical development.  

The article, titled “Spending on phased clinical development of approved drugs by the US National Institutes of Health compared with industry“ is the first to broadly assess the NIH contribution to clinical development of new drugs and compare the scale of NIH spending relative to reported spending by industry. The study shows that NIH funding represented only ~10% of reported industry costs for phased clinical trials and was largely limited to programs designed to advance clinical and translational science in general by supporting centers, core capabilities, and training.

“This analysis confirms previous studies showing that the NIH makes substantive investments in the basic and applied science underlying new drugs, but also demonstrates that the NIH makes only limited contributions to development” said Fred Ledley, Director of the Center for Integration of Science and Industry, and the senior author on this study. “This is consistent with policies that position the public sector as an early investor in pharmaceutical innovations that are subsequently developed and commercialized by the pharmaceutical industry.”

This study identified $247 billion in total NIH funding contributing to more than 2.5 million publications describing basic or applied research related to 386 of 387 drugs approved 2010-2019 with $8.1 billion (3.3%) related to phased clinical development. This funding contributed to >12 thousand publications describing phased clinical trials involving 240 of 387 (62%) approved drugs. Average NIH spending was $33.8 million per approved drug and was significantly lower than reported industry spending. Overall, NIH spending represented ~10% of reported industry spending including ~25% of phase 1 costs, ~22% of phase 2 costs, and ~4% of phase 3 costs. More than 90% of NIH funding came through mechanisms designed to advance the practice of translational science or support programs or centers that provide clinical research capabilities, patient networks or consortia, or training in clinical, translational, or regulatory science (including Clinical Translational Science Awards). Only 3.3% of the total NIH funding was provided through mechanisms that support investigator-initiated research.

 

Dr. Edward Zhou was the lead author of this work along with Dr. Matthew Jackson and Dr. Ledley.

This work was supported by grants from the National Pharmaceutical Council and the National Biomedical Research Foundation.

THE CENTER FOR INTEGRATION OF SCIENCE AND INDUSTRY at Bentley University focuses on advancing the translation of scientific discoveries to create public value. The Center is an environment for interdisciplinary scholarship spanning basic science, data analytics, business, and public policy. For more information, visit www.bentley.edu/sciindustry and follow us on Twitter @sciindustry and LinkedIn.

BENTLEY UNIVERSITY is more than just one of the nation's top business schools. It is a lifelong-learning community that creates successful leaders who make business a force for positive change. With a combination of business and the arts and sciences and a flexible, personalized approach to education, Bentley provides students with critical thinking and practical skills that prepare them to lead successful, rewarding careers. Founded in 1917, the university enrolls 4,100 undergraduate and 1,000 graduate and PhD students and is set on 163 acres in Waltham, Massachusetts, 10 miles west of Boston. For more information, visit bentley.edu. For more information, visit bentley.edu. Follow us on Twitter @BentleyU #BentleyUResearch.

END

[Attachments] See images for this press release:
NIH spent $8.1B for phased clinical trials of drugs approved 2010-19, ~10% of reported industry spending NIH spent $8.1B for phased clinical trials of drugs approved 2010-19, ~10% of reported industry spending 2 NIH spent $8.1B for phased clinical trials of drugs approved 2010-19, ~10% of reported industry spending 3

ELSE PRESS RELEASES FROM THIS DATE:

Coordination could spare billions in grid upgrade costs and accelerate electrification

Coordination could spare billions in grid upgrade costs and accelerate electrification
2023-07-14
The electric grids of the future will need to handle much bigger loads due to electrification of transportation and other sectors. This could mean expensive infrastructure upgrades to ensure their reliable operation, but a new study from Stanford University says most of those upgrades may be unnecessary. Better grid reliability could be achieved instead by installing software in homes and businesses that coordinates various consumer demands and resources. Such coordination not only improves reliability of the electric grid, but also ...

Conditional cash transfer programs have prevented 739,919 child deaths in Latin America

2023-07-14
Over the past two decades, conditional cash transfer programmes have led to a 24% reduction in child mortality in Brazil, Mexico and Ecuador, equivalent to more than 700,000 child deaths averted, according to an impact evaluation study led by the Barcelona Institute for Global Health (ISGlobal), an institution supported by “la Caixa” Foundation. The results, published in JAMA Network Open, also show that expanding these programmes could save more than 150,ooo lives by mitigating the effects of the ...

Neighborhood racial segregation linked to shorter life spans by four years

2023-07-14
New nationwide study is first to examine implications of racial segregation on life expectancy by neighborhood Findings quantify how neighborhood segregation contributes to racial inequities in life expectancy Black residents living in heavily segregated areas experienced higher rates of poverty and unemployment and less education CHICAGO --- Black residents living in highly segregated neighborhoods have significantly shortened life expectancies, reports a new Northwestern Medicine study. Compared to residents living in less segregated predominantly ...

Fintetuning for antibodies

2023-07-14
Antibodies are crucial, not only for treating tumors and infections. Sometimes, however, the immune reaction they trigger can be too strong and end up causing more damage, for example in the case of people infected with Covid-19. Problems such as these can often be avoided by finetuning antibodies, as Prof. Dr. Falk Nimmerjahn from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and two of his colleagues in the Netherlands and in the UK have now reported in the journal Nature Immunology. In his laboratories, the FAU researcher is carrying out research into immunoglobulin ...

Single-end hybrid Rayleigh Brillouin and Raman distributed fibre-optic sensing system

Single-end hybrid Rayleigh Brillouin and Raman distributed fibre-optic sensing system
2023-07-14
The real-time monitoring of facilities, particularly large facilities (such as rail transit systems, large bridges, and buildings), can provide information regarding their surrounding environment and allow their health conditions to be assessed, which is essential for establishing the current concept of smart cities based on the Internet of Things. As a precise real-time monitoring technique, distributed fiber-optic sensing (DFOS) systems, which require long-distance simultaneous measurements along a sensing fiber, are in high demand for various industrial applications. However, ...

Why trees outcompete shrubs to shift upward?

Why trees outcompete shrubs to shift upward?
2023-07-14
The findings from this study, led by Professor Eryuan Liang (Institute of Tibetan Plateau Research, Chinese Academy of Sciences), were published as a research article in the journal National Science Review. The study also involved researchers from, CREAF, CSIC, Global Ecology Unit CREAF-CSIC-UAB, Instituto Pirenaico de Ecología (IPE-CSIC), Spain and Université du Québec à Chicoutimi, Canada. Climatic warming is altering the structure and function of alpine ecosystems, including shifts of vegetation boundaries. The upward shift of alpine treelines, the uppermost limit of tree growth forming the boundary between montane forest and alpine communities, ...

New fossil flying reptile ‘Elvis’ takes flight

New fossil flying reptile ‘Elvis’ takes flight
2023-07-14
A new 145-million-year-old pterosaur (extinct flying reptiles that lived alongside the dinosaurs) was named today by a team of British, American and German researchers. The animal was nicknamed ‘Elvis’ when the fossil was first unearthed in Bavaria, Germany because of the giant pompadour-like bony crest on its skull.  Now the animal has been given a formal scientific name of Petrodactyle wellnhoferi. The name translates as ‘Wellnhofer’s stone-finger’ honouring legendary German palaeontologist ...

m6A mRNA modification potentiates Th17 functions to inflame autoimmunity

m6A mRNA modification potentiates Th17 functions to inflame autoimmunity
2023-07-14
N6-methyladenosine (m6A) is the most extensive studied RNA modification across various species, and the important effect of m6A modification in immune system has been revealed in distinct contexts, including mRNA metabolism, cell differentiation, proliferation and response to stimulation. Previous studies from Hua-Bing Li group demonstrated that m6A methyltransferase METTL3 control T cells homeostasis and sustain the suppressive function of regulatory T cells (Tregs). However, the role of m6A methyltransferase in other subtype of T cells remains unknown. T helper cells 17 ...

Exercise during dialysis has positive health impact

2023-07-14
Patients who engage in light exercise while undergoing dialysis are physically fitter and are admitted to hospital less frequently than those who do not. These are the findings of a large-scale study conducted by a consortium led by the Technical University of Munich (TUM). The researchers believe that exercise programs should be offered to dialysis patients as standard. Around 558,000 people in the United States have such severely impaired kidney function that they require dialysis several times per week. In Germany, about 80,000 people regularly undergo ...

Link between oropharyngeal cancer and sexual behavior

2023-07-14
Human papillomavirus (HPV) is a ubiquitous virus, and most people are infected at some point in their lives. HPV can infect epithelial cells of the skin and mucosa at various sites. There are more than 100 known HPV subtypes, most of which cause only benign lesions such as warts and condyloma. Thanks to a well-functioning immune response, most people who are infected don’t develop serious symptoms. However, some HPV subtypes are not so harmless. These subtypes, and especially subtype HPV16, can transform infected cells to become neoplastic, and these malignant transformed cells then develop into precancerous ...

LAST 30 PRESS RELEASES:

Novel treatment combination improves progression-free survival in metastatic, estrogen-receptor-positive HER-2-negative breast cancer

ESMO 2025: Trial results show belzutifan shrinks rare neuroendocrine tumors and improves symptoms in patients

ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer patients

New generation of Antibody-Drug Conjugates (ADCs) shows unprecedented promise in early-stage disease

Sylvester Cancer Tip Sheet for October 2025

Three science and technology leaders elected to Hertz Foundation Board of Directors

Jump Trading CSO Kevin Bowers elected to Hertz Foundation Board of Directors

Former Inscripta CEO Sri Kosaraju elected to Hertz Foundation Board of Directors

Citadel’s Jordan Chetty elected to Hertz Foundation Board of Directors

McGill research flags Montreal snow dump, inactive landfills as major methane polluters

A lightweight and rapid bidirectional search algorithm

Eighty-five years of big tree history available in one place for the first time

MIT invents human brain model with six major cell types to enable personalized disease research, drug discovery

Health and economic air quality co-benefits of stringent climate policies

How immune cells deliver their deadly cargo

How the brain becomes a better listener: How focus enhances sound processing

Processed fats found in margarines unlikely to affect heart health

Scientists discover how leukemia cells evade treatment

Sandra Shi MD, MPH, named 2025 STAT Wunderkind

Treating liver disease with microscopic nanoparticles

Chemicals might be hitching a ride on nanoplastics to enter your skin

Pregnant patients with preexisting high cholesterol may have elevated CV risk

UC stroke experts discuss current and future use of AI tools in research and treatment

The Southern Ocean’s low-salinity water locked away CO2 for decades, but...

OHSU researchers develop functional eggs from human skin cells

Most users cannot identify AI bias, even in training data

Hurricane outages: Analysis details the where, and who, of increased future power cuts

Craters on surface of melanoma cells found to serve as sites for tumor killing

Research Spotlight: Mapping overlooked challenges in stroke recovery

Geographic and temporal patterns of screening for breast, cervical, and colorectal cancer in the US

[Press-News.org] NIH spent $8.1B for phased clinical trials of drugs approved 2010-19, ~10% of reported industry spending
Bentley University study further describes public and private sector investments in pharmaceutical innovation